These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 14374026)

  • 1. [Meningitis caused by Pseudomonas aeruginosa, treated by polymyxin B].
    MABILLE ; BERNES ; COCHINARD
    Tunis Med; 1955 Feb; 43(2):159-61. PubMed ID: 14374026
    [No Abstract]   [Full Text] [Related]  

  • 2. Meningitis due to Pseudomonas pyocyanea successfully treated with polymyxin B.
    LOVELL-SMITH HD
    N Z Med J; 1954 Oct; 53(297):520-3. PubMed ID: 13214493
    [No Abstract]   [Full Text] [Related]  

  • 3. A fatal case of meningitis due to Pseudomonas aeruginosa following an upper respiratory infection.
    WIDERMAN A
    J Albert Einstein Med Cent (Phila); 1953 Nov; 2(1):31-4. PubMed ID: 13108454
    [No Abstract]   [Full Text] [Related]  

  • 4. [Polymyxin Treated pseudomonas meningitis].
    ENGSTEDT L; OLHAGEN B
    Sven Lakartidn; 1955 Jan; 52(4):196-201. PubMed ID: 14373469
    [No Abstract]   [Full Text] [Related]  

  • 5. Pseudomonas pyocyanea meningitis successfully treated with polymyxin.
    TRAPNELL DH
    Lancet; 1954 Apr; 266(6815):759-61. PubMed ID: 13153108
    [No Abstract]   [Full Text] [Related]  

  • 6. [Bacterial meningitis and Pseudomonas aeruginosa: apropos of a case].
    Batlle Almodóvar Mdel C; Dickinson F; Pérez Monrás M; Tamargo Martínez I; Similis A
    Rev Cubana Med Trop; 2005; 57(3):230-2. PubMed ID: 17969281
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intravenous polymyxin B for the treatment of nosocomial pneumonia caused by multidrug-resistant Pseudomonas aeruginosa.
    Furtado GH; d'Azevedo PA; Santos AF; Gales AC; Pignatari AC; Medeiros EA
    Int J Antimicrob Agents; 2007 Oct; 30(4):315-9. PubMed ID: 17631984
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Aerosporin treatment of pyocyaneus meningitis].
    BONZANIGO C; MOLO C
    Ann Paediatr; 1953; 180(4-5):268-72. PubMed ID: 13065888
    [No Abstract]   [Full Text] [Related]  

  • 9. Multidrug-resistant Pseudomonas aeruginosa infection in neutropenic patients successfully treated with a combination of polymyxin B and rifampin.
    Ostronoff M; Ostronoff F; Sucupira A; Souto Maior AP; Caniza M; Florêncio R; Domingues MC; Calixto R; Matias K
    Int J Infect Dis; 2006 Jul; 10(4):339-40. PubMed ID: 16412679
    [No Abstract]   [Full Text] [Related]  

  • 10. A single amino acid substitution in PmrB is associated with polymyxin B resistance in clinical isolate of Pseudomonas aeruginosa.
    Abraham N; Kwon DH
    FEMS Microbiol Lett; 2009 Sep; 298(2):249-54. PubMed ID: 19663916
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Colistin and polymyxin B in critical care.
    Michalopoulos A; Falagas ME
    Crit Care Clin; 2008 Apr; 24(2):377-91, x. PubMed ID: 18361952
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Successful treatment of multidrug-resistant Pseudomonas aeruginosa meningitis with intravenous and intrathecal colistin.
    Schina M; Spyridi E; Daoudakis M; Mertzanos E; Korfias S
    Int J Infect Dis; 2006 Mar; 10(2):178-9. PubMed ID: 16263315
    [No Abstract]   [Full Text] [Related]  

  • 13. [Rapid cure of pneumococcus meningitis with toxic state in an infant 13 months old, treated with ACTH and antibiotics].
    IMBERT P; JOUVET M; DUMONT R
    Pediatrie; 1953; 8(6):725-7. PubMed ID: 13120295
    [No Abstract]   [Full Text] [Related]  

  • 14. Combination therapy with polymyxin B for the treatment of multidrug-resistant Gram-negative respiratory tract infections.
    Sobieszczyk ME; Furuya EY; Hay CM; Pancholi P; Della-Latta P; Hammer SM; Kubin CJ
    J Antimicrob Chemother; 2004 Aug; 54(2):566-9. PubMed ID: 15269195
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Citywide emergence of Pseudomonas aeruginosa strains with reduced susceptibility to polymyxin B.
    Landman D; Bratu S; Alam M; Quale J
    J Antimicrob Chemother; 2005 Jun; 55(6):954-7. PubMed ID: 15883174
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Salvage treatment of pneumonia and initial treatment of tracheobronchitis caused by multidrug-resistant Gram-negative bacilli with inhaled polymyxin B.
    Pereira GH; Muller PR; Levin AS
    Diagn Microbiol Infect Dis; 2007 Jun; 58(2):235-40. PubMed ID: 17350201
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Polymyxin B for the treatment of multidrug-resistant pathogens: a critical review.
    Zavascki AP; Goldani LZ; Li J; Nation RL
    J Antimicrob Chemother; 2007 Dec; 60(6):1206-15. PubMed ID: 17878146
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pitfalls of polymyxin antimicrobial susceptibility testing of Pseudomonas aeruginosa isolated from cystic fibrosis patients.
    Hogardt M; Schmoldt S; Götzfried M; Adler K; Heesemann J
    J Antimicrob Chemother; 2004 Dec; 54(6):1057-61. PubMed ID: 15509615
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [A case of meningitis due to Actinomyces israeli; cure by antibiotic treatment of several months duration].
    MULLER B; RAOUL-DUVAL P; BAYLE J; BOUVET R; NAUDIN G
    Lyon Med; 1954 Aug; 86(32):117-26. PubMed ID: 13202556
    [No Abstract]   [Full Text] [Related]  

  • 20. In vitro and in vivo potency of polymyxin B against IMP-type metallo-beta-lactamase-producing Pseudomonas aeruginosa.
    Miyajima Y; Hiramatsu K; Mizukami E; Morinaga R; Ishii H; Shirai R; Kishi K; Tokimatsu I; Saikawa T; Kadota J
    Int J Antimicrob Agents; 2008 Nov; 32(5):437-40. PubMed ID: 18715759
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.